Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Multimodal single-cell analysis of nonrandom heteroplasmy distribution in human retinal mitochondrial disease
Nathaniel K. Mullin, … , Budd A. Tucker, Robert F. Mullins
Nathaniel K. Mullin, … , Budd A. Tucker, Robert F. Mullins
Published June 8, 2023
Citation Information: JCI Insight. 2023;8(14):e165937. https://doi.org/10.1172/jci.insight.165937.
View: Text | PDF
Research Article Genetics Ophthalmology

Multimodal single-cell analysis of nonrandom heteroplasmy distribution in human retinal mitochondrial disease

  • Text
  • PDF
Abstract

Variants within the high copy number mitochondrial genome (mtDNA) can disrupt organelle function and lead to severe multisystem disease. The wide range of manifestations observed in patients with mitochondrial disease results from varying fractions of abnormal mtDNA molecules in different cells and tissues, a phenomenon termed heteroplasmy. However, the landscape of heteroplasmy across cell types within tissues and its influence on phenotype expression in affected patients remains largely unexplored. Here, we identify nonrandom distribution of a pathogenic mtDNA variant across a complex tissue using single-cell RNA-Seq, mitochondrial single-cell ATAC sequencing, and multimodal single-cell sequencing. We profiled the transcriptome, chromatin accessibility state, and heteroplasmy in cells from the eyes of a patient with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) and from healthy control donors. Utilizing the retina as a model for complex multilineage tissues, we found that the proportion of the pathogenic m.3243A>G allele was neither evenly nor randomly distributed across diverse cell types. All neuroectoderm-derived neural cells exhibited a high percentage of the mutant variant. However, a subset of mesoderm-derived lineage, namely the vasculature of the choroid, was near homoplasmic for the WT allele. Gene expression and chromatin accessibility profiles of cell types with high and low proportions of m.3243A>G implicate mTOR signaling in the cellular response to heteroplasmy. We further found by multimodal single-cell sequencing of retinal pigment epithelial cells that a high proportion of the pathogenic mtDNA variant was associated with transcriptionally and morphologically abnormal cells. Together, these findings show the nonrandom nature of mitochondrial variant partitioning in human mitochondrial disease and underscore its implications for mitochondrial disease pathogenesis and treatment.

Authors

Nathaniel K. Mullin, Andrew P. Voigt, Miles J. Flamme-Wiese, Xiuying Liu, Megan J. Riker, Katayoun Varzavand, Edwin M. Stone, Budd A. Tucker, Robert F. Mullins

×

Figure 6

Multimodal sequencing of MELAS and control retina, RPE, and choroid cells.

Options: View larger image (or click on image) Download as PowerPoint
Multimodal sequencing of MELAS and control retina, RPE, and choroid cell...
(A) Schematic of multimodal sequencing approach to measure gene expression, nuclear chromatin accessibility, and heteroplasmy in individual cells isolated from the retina and RPE/choroid. (B) Two-dimensional UMAP embeddings of neural retinal cells from the MELAS proband and controls based on weighted nearest neighbor (WNN) analysis of scRNA-Seq and mt-scATAC–Seq data. (C) Two-dimensional UMAP embeddings of RPE/choroidal cells from the MELAS proband and controls based on WNN analysis of scRNA-Seq and mt-scATAC–Seq data. (D) Two-dimensional UMAP embedding of neural retinal cells recovered from the proband. Individual cells are colored based on proportion of m.3243A>G mutant allele (red indicating 100% mutant allele and blue indicating 100% WT allele). (E) Two-dimensional UMAP embedding of RPE and choroid cells recovered from the proband samples. Individual cells are colored based on proportion of m.3243A>G mutant allele (red indicating 100% mutant allele and blue indicating 100% WT allele). (F) Volcano plot showing differentially expressed genes between the virtually homoplamic MELAS RPE and RPE cells from the control donors. (G) Pathway enrichment analysis for differentially expressed genes in F. Genes involved in cholesterol biosynthesis are deenriched in the MELAS RPE cells compared with control RPE.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts